InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904

Related Stories

Lung Fung (2290) Achieves Record-High Annual Revenue and Net Profit

Solvexel Energy Technologies (SET) Launches Global Expansion Initiative and Innovative Digital Energy Management Platform

Reconova Launches Hong Kong IPO, Rare Embodied Vision AI Candidate Hits Home Stretch

Doubleview Provides Hat Project Development Update as Ongoing Drilling Supports Next Mineral Resource Estimate and Pre-Feasibility Advancement

Regina Miracle FY26 Net Profit Up by 53.9% to HK$280 Million

WordSearchZen.com Expands Open-Access Educational Utilities Amid Rising Demand for Printable Learning Materials

You may have missed

Lung Fung (2290) Achieves Record-High Annual Revenue and Net Profit

Solvexel Energy Technologies (SET) Launches Global Expansion Initiative and Innovative Digital Energy Management Platform

Reconova Launches Hong Kong IPO, Rare Embodied Vision AI Candidate Hits Home Stretch

Doubleview Provides Hat Project Development Update as Ongoing Drilling Supports Next Mineral Resource Estimate and Pre-Feasibility Advancement

Regina Miracle FY26 Net Profit Up by 53.9% to HK$280 Million

error: Content is protected !!